A detailed history of Reap Financial Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Reap Financial Group, LLC holds 442 shares of MRK stock, worth $40,036. This represents 0.01% of its overall portfolio holdings.

Number of Shares
442
Previous 471 6.16%
Holding current value
$40,036
Previous $53.5 Million 17.85%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 27, 2025

SELL
$96.31 - $114.76 $2,792 - $3,328
-29 Reduced 6.16%
442 $43.9 Million
Q3 2024

Feb 27, 2025

BUY
$111.15 - $128.97 $15,783 - $18,313
142 Added 43.16%
471 $53.5 Million
Q2 2024

Feb 27, 2025

BUY
$123.8 - $132.96 $7,799 - $8,376
63 Added 23.68%
329 $40.8 Million
Q1 2024

Feb 27, 2025

SELL
$113.24 - $131.95 $165,103 - $192,383
-1,458 Reduced 84.57%
266 $35.1 Million
Q4 2023

Feb 27, 2025

BUY
$100.18 - $109.02 $172,710 - $187,950
1,724 New
1,724 $188 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $229B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Reap Financial Group, LLC Portfolio

Follow Reap Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reap Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reap Financial Group, LLC with notifications on news.